Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Mayo Clinic presents data on new aldehyde dehydrogenase inhibitor at ASCPT meeting

March 8, 2001

CeNeS cleared to commence clinical trial of treatment for alcohol addiction

March 2, 2001

Chelating drug to be codeveloped by Biomedical Frontiers and Chiesii

March 2, 2001

Therapeutic agents for drug addiction, withdrawal, etc., claimed by Knoll

Feb. 22, 2001

CroFab now available in the U.S. for treatment of poisonous snakebites

Feb. 1, 2001

Anticocaine catalytic MAb selectively attenuates cocaine selfadministration in rats

Jan. 9, 2001

FDA approves second indication for Antizol

Dec. 13, 2000

Antizol approved in Canada for treatment of ethylene glycol poisoning

Dec. 6, 2000

Novel, orally active iron chelator APO-363: preclinical pharmacokinetics reported at AAPS

Nov. 7, 2000

NIDA grant awarded to Nabi for nicotine vaccine research

Oct. 10, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 28, 2025
Roche looks to grow with sequencing by expansion tech
BioWorld MedTech
Roche Holding AG revealed plans to launch its sequencing by expansion technology next year, raising the possibility that rival Illumina Inc. could face a real run...
Clots and metastasis in cancer patients start in the lung
BioWorld MedTech
The lung and thrombosis may play a key role in cancer and metastasis progression, according to a collaborative study led by Cornell University scientists. In the...
Evo 2 AI allows genome and epigenome modeling of all life domains
BioWorld MedTech
A new version of Evo, the AI developed at the Arc Institute that can be used to design genomes as long as that of a bacterium, has been retrained with the DNA...